Druggio Logo

Druggio

Sato Pharmaceutical

Sato Pharmaceutical is a leading Japanese pharmaceutical company founded in 1915. The company focuses on the development and manufacturing of a wide range of pharmaceutical products, including over-the-counter medicines, medical devices, and consumer healthcare products. Sato Pharmaceutical's primary focus areas include gastroenterology, dermatology, and pain management. They have a strong portfolio of drugs and treatments for various conditions, such as gastrointestinal disorders, skin diseases, and pain management.

Sato Pharmaceutical's Drugs

Nailin

Approval date

2018/1/19

Emla

Approval date

2012/1/18

Thyrogen

Approval date

2008/10/16